BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32798842)

  • 21. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease.
    Yilmaz FT; Özkaynak SS; Barçin E
    Neurol Sci; 2017 Dec; 38(12):2103-2109. PubMed ID: 28887694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification and staging of Parkinson's disease using video-based eye tracking.
    Brien DC; Riek HC; Yep R; Huang J; Coe B; Areshenkoff C; Grimes D; Jog M; Lang A; Marras C; Masellis M; McLaughlin P; Peltsch A; Roberts A; Tan B; Beaton D; Lou W; Swartz R; ; Munoz DP
    Parkinsonism Relat Disord; 2023 May; 110():105316. PubMed ID: 36822878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the occurrence of mild cognitive impairment in Parkinson's disease using structural MRI data.
    Beheshti I; Ko JH
    Front Neurosci; 2024; 18():1375395. PubMed ID: 38699676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning.
    Cengiz S; Arslan DB; Kicik A; Erdogdu E; Yildirim M; Hatay GH; Tufekcioglu Z; Uluğ AM; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
    MAGMA; 2022 Dec; 35(6):997-1008. PubMed ID: 35867235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases.
    Hessen E; Stav AL; Auning E; Selnes P; Blomsø L; Holmeide CE; Johansen KK; Eliassen CF; Reinvang I; Fladby T; Aarsland D
    J Parkinsons Dis; 2016 Apr; 6(2):413-21. PubMed ID: 27061068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. fNIRS-based graph frequency analysis to identify mild cognitive impairment in Parkinson's disease.
    Shu Z; Wang J; Cheng Y; Lu J; Lin J; Wang Y; Zhang X; Yu Y; Zhu Z; Han J; Wu J; Yu N
    J Neurosci Methods; 2024 Feb; 402():110031. PubMed ID: 38040127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.
    Cecchini MP; Federico A; Zanini A; Mantovani E; Masala C; Tinazzi M; Tamburin S
    J Neural Transm (Vienna); 2019 May; 126(5):585-595. PubMed ID: 30911822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease.
    Wu H; Khuram Raza H; Li Z; Li Z; Zu J; Xu C; Yang D; Cui G
    J Clin Neurosci; 2022 Jun; 100():192-195. PubMed ID: 35489254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning for automated EEG-based biomarkers of cognitive impairment during Deep Brain Stimulation screening in patients with Parkinson's Disease.
    Geraedts VJ; Koch M; Contarino MF; Middelkoop HAM; Wang H; van Hilten JJ; Bäck THW; Tannemaat MR
    Clin Neurophysiol; 2021 May; 132(5):1041-1048. PubMed ID: 33743299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning can predict mild cognitive impairment in Parkinson's disease.
    Amboni M; Ricciardi C; Adamo S; Nicolai E; Volzone A; Erro R; Cuoco S; Cesarelli G; Basso L; D'Addio G; Salvatore M; Pace L; Barone P
    Front Neurol; 2022; 13():1010147. PubMed ID: 36468069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of Parkinson's disease through patient questionnaire and predictive modelling.
    Prashanth R; Dutta Roy S
    Int J Med Inform; 2018 Nov; 119():75-87. PubMed ID: 30342689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.